AU2003217942A1 - Modulators of leukocyte activation, compositions, and methods of use - Google Patents

Modulators of leukocyte activation, compositions, and methods of use

Info

Publication number
AU2003217942A1
AU2003217942A1 AU2003217942A AU2003217942A AU2003217942A1 AU 2003217942 A1 AU2003217942 A1 AU 2003217942A1 AU 2003217942 A AU2003217942 A AU 2003217942A AU 2003217942 A AU2003217942 A AU 2003217942A AU 2003217942 A1 AU2003217942 A1 AU 2003217942A1
Authority
AU
Australia
Prior art keywords
modulators
compositions
methods
leukocyte activation
leukocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003217942A
Other versions
AU2003217942A8 (en
Inventor
Annabelle M. Friera
Esteban Masuda
Mark Powell
Marcy K. Vallone
Brian Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rigel Pharmaceuticals Inc
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of AU2003217942A1 publication Critical patent/AU2003217942A1/en
Publication of AU2003217942A8 publication Critical patent/AU2003217942A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003217942A 2002-03-01 2003-03-03 Modulators of leukocyte activation, compositions, and methods of use Abandoned AU2003217942A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US36062302P 2002-03-01 2002-03-01
US36079702P 2002-03-01 2002-03-01
US36067002P 2002-03-01 2002-03-01
US36062402P 2002-03-01 2002-03-01
US36079602P 2002-03-01 2002-03-01
US60/360,670 2002-03-01
US60/360,796 2002-03-01
US60/360,797 2002-03-01
US60/360,623 2002-03-01
US60/360,624 2002-03-01
US36443702P 2002-03-15 2002-03-15
US60/364,437 2002-03-15
PCT/US2003/006748 WO2003074007A2 (en) 2002-03-01 2003-03-03 Modulators of leukocyte activation, compositions, and methods of use

Publications (2)

Publication Number Publication Date
AU2003217942A1 true AU2003217942A1 (en) 2003-09-16
AU2003217942A8 AU2003217942A8 (en) 2003-09-16

Family

ID=27792375

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003217942A Abandoned AU2003217942A1 (en) 2002-03-01 2003-03-03 Modulators of leukocyte activation, compositions, and methods of use

Country Status (2)

Country Link
AU (1) AU2003217942A1 (en)
WO (1) WO2003074007A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222276D0 (en) * 2002-09-25 2002-10-30 Inst Of Molecul & Cell Biology Methods
GB0307472D0 (en) * 2003-04-01 2003-05-07 Lorantis Ltd Medical treatment
US20090233848A1 (en) * 2004-03-09 2009-09-17 Chandra Bartholomeusz Pea15 as a Tumor Suppressor Gene
ES2327694B1 (en) * 2005-12-29 2010-10-14 Consejo Superior Investig. Cientificas SELECTIVE INHIBITORS PEPTIDES OF THE BIOLOGICAL ACTIVITY OF THE CALCINEURINE.
CN106519005B (en) * 2016-11-14 2019-12-24 深圳大学 Phosphorylated NFAT3 mutant and application thereof
EP3635402B1 (en) * 2017-05-22 2024-01-24 Edith Cowan University Biomarker of disease
EP3914726A4 (en) * 2019-01-24 2022-09-21 Council of Scientific & Industrial Research Kit for detecting melanoma
US20230020401A1 (en) * 2019-11-08 2023-01-19 Sanford Burnham Prebys Medical Discovery Institute Metabolic reprogramming of immune cells to enhance the efficacy of prophylactic and therapeutic vaccines

Also Published As

Publication number Publication date
WO2003074007A2 (en) 2003-09-12
WO2003074007A3 (en) 2004-10-28
AU2003217942A8 (en) 2003-09-16

Similar Documents

Publication Publication Date Title
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2003291668A1 (en) Sacrificial compositions, methods of use thereof, and methods of decomposition thereof
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2003248721A1 (en) Adsorbents, methods of preparation, and methods of use thereof
AU2003295801A1 (en) MODULATION OF HIF1Alpha AND HIF2Alpha EXPRESSION
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003228445A1 (en) Tissue composites and uses thereof
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003294778A1 (en) Novel use of lycopene
AU2003259717A1 (en) Modulators of rabggt and methods of use thereof
AU2003239614A1 (en) Cardiolipin compositions, methods of preparation and use
AU2003299441A1 (en) Nf-hev compositions and methods of use
AU2003275268A1 (en) Hemostatic compositions and methods
AU2003247351A1 (en) Anti-acne compositions and methods of use
AU2003275056A1 (en) Novel lapacho compounds and methods of use thereof
AU2003271183A1 (en) Block copolymer and application thereof
AU2003213120A1 (en) Human rnase iii and compositions and uses thereof
AU2002362589A1 (en) Basecoat composition and application methods therewith
AU2002361337A1 (en) Amphoteric polysaccharide, composition and use
AU2003233445A1 (en) Antimicrobial compositions and methods of use
AU2003217942A1 (en) Modulators of leukocyte activation, compositions, and methods of use
AU2003293765A1 (en) Novel skin lightening agents, compositions and methods
AU2003287802A1 (en) Palpometer and methods of use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase